Macrophages: Key regulators of steady-state and demand-adapted hematopoiesis

Experimental Hematology

Volumn 44, Issue 4, 2016, Pages 213-222

  McCabe, Amanda ^a   MacNamara, Katherine C ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; PLERIXAFOR;

BONE MARROW DERIVED MACROPHAGE; CYTOKINE RESPONSE; DRUG EFFECT; EHRLICHIOSIS; EMBRYO DEVELOPMENT; EXTRAMEDULLARY HEMATOPOIESIS; GRANULOPOIESIS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEADY STATE; STEM CELL MOBILIZATION; ANIMAL; BONE MARROW CELL; CELL DIFFERENTIATION; CYTOLOGY; METABOLISM; PHENOTYPE; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MACROPHAGES; PHENOTYPE; STRESS, PHYSIOLOGICAL;

EID: 84960801240     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2016.01.003     Document Type: Review

References (106)

1. Chow A., Huggins M., Ahmed J., et al. CD169(+) macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat Med 2013, 19:429-436.
2. Giger K.M., Kalfa T.A. Phylogenetic and ontogenetic view of erythroblastic islands. BioMed Res Int 2015, 2015:873628.
3. Ramos P., Casu C., Gardenghi S., et al. Macrophages support pathological erythropoiesis in polycythemia vera and beta-thalassemia. Nat Med 2013, 19:437-445.
4. Sadahira Y., Mori M. Role of the macrophage in erythropoiesis. Pathol Int 1999, 49:841-848.
5. Classen A., Lloberas J., Celada A. Macrophage activation: Classical versus alternative. Methods Mol Biol 2009, 531:29-43.
6. Mosser D.M. The many faces of macrophage activation. J Leukoc Biol 2003, 73:209-212.
7. Van Furth R., Cohn Z.A. The origin and kinetics of mononuclear phagocytes. J Exp Med 1968, 128:415-435.
8. Hashimoto D., Chow A., Noizat C., et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 2013, 38:792-804.
9. Epelman S., Lavine K.J., Beaudin A.E., et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 2014, 40:91-104.
10. Ginhoux F., Greter M., Leboeuf M., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010, 330:841-845.
11. Gomez Perdiguero E., Klapproth K., Schulz C., et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 2015, 518:547-551.
12. Guilliams M., De Kleer I., Henri S., et al. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J Exp Med 2013, 210:1977-1992.
13. Hoeffel G., Chen J., Lavin Y., et al. C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. Immunity 2015, 42:665-678.
14. Schulz C., Gomez Perdiguero E., Chorro L., et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012, 336:86-90.
15. Sheng J., Ruedl C., Karjalainen K. Most Tissue-resident macrophages except microglia are derived from fetal hematopoietic stem cells. Immunity 2015, 43:382-393.
16. Yona S., Kim K.W., Wolf Y., et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 2013, 38:79-91.
17. Hom J., Dulmovits B.M., Mohandas N., Blanc L. The erythroblastic island as an emerging paradigm in the anemia of inflammation. Immunol Res 2015, 63:75-89.
18. Chow A., Lucas D., Hidalgo A., et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med 2011, 208:261-271.
19. Winkler I.G., Sims N.A., Pettit A.R., et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 2010, 116:4815-4828.
20. Alexander K.A., Chang M.K., Maylin E.R., et al. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res 2011, 26:1517-1532.
21. Chang M.K., Raggatt L.J., Alexander K.A., et al. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol 2008, 181:1232-1244.
22. Casanova-Acebes M., Pitaval C., Weiss L.A., et al. Rhythmic Modulation of the hematopoietic niche through neutrophil clearance. Cell 2013, 153:1025-1035.
23. Furze R.C., Rankin S.M. The role of the bone marrow in neutrophil clearance under homeostatic conditions in the mouse. FASEB J 2008, 22:3111-3119.
24. Gordy C., Pua H., Sempowski G.D., He Y.W. Regulation of steady-state neutrophil homeostasis by macrophages. Blood 2011, 117:618-629.
25. Stark M.A., Huo Y., Burcin T.L., Morris M.A., Olson T.S., Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005, 22:285-294.
26. Bessis M. [Erythroblastic island, functional unity of bone marrow]. Rev Hematol 1958, 13:8-11.
27. Bessis M.C., Breton-Gorius J. Iron metabolism in the bone marrow as seen by electron microscopy: A critical review. Blood 1962, 19:635-663.
28. Crocker P.R., Gordon S. Isolation and characterization of resident stromal macrophages and hematopoietic cell clusters from mouse bone marrow. J Exp Med 1985, 162:993-1014.
29. Chasis J.A., Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood 2008, 112:470-478.
30. Wu A.C., Raggatt L.J., Alexander K.A., Pettit A.R. Unraveling macrophage contributions to bone repair. Bonekey Rep 2013, 2:373.
31. Crocker P.R., Werb Z., Gordon S., Bainton D.F. Ultrastructural localization of a macrophage-restricted sialic acid binding hemagglutinin, SER, in macrophage-hematopoietic cell clusters. Blood 1990, 76:1131-1138.
32. Hume D.A., Robinson A.P., MacPherson G.G., Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80: Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. J Exp Med 1983, 158:1522-1536.
33. Sadahira Y., Yoshino T., Monobe Y. Very late activation antigen 4-vascular cell adhesion molecule 1 interaction is involved in the formation of erythroblastic islands. J Exp Med 1995, 181:411-415.
34. Delputte P.L., Van Gorp H., Favoreel H.W., et al. Porcine sialoadhesin (CD169/Siglec-1) is an endocytic receptor that allows targeted delivery of toxins and antigens to macrophages. PLoS One 2011, 6:e16827.
35. Mevorach D., Mascarenhas J.O., Gershov D., Elkon K.B. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 1998, 188:2313-2320.
36. Osborn L., Hession C., Tizard R., et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989, 59:1203-1211.
37. Rice G.E., Munro J.M., Bevilacqua M.P. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes: A CD11/CD18-independent adhesion mechanism. J Exp Med 1990, 171:1369-1374.
38. Jacobsen R.N., Forristal C.E., Raggatt L.J., et al. Mobilization with granulocyte colony-stimulating factor blocks medullar erythropoiesis by depleting F4/80(+)VCAM1(+)CD169(+)ER-HR3(+)Ly6G(+) erythroid island macrophages in the mouse. Exp Hematol 2014, 42:547-561.e544.
39. McCabe A., Zhang Y., Thai V., Jones M., Jordan M.B., MacNamara K.C. Macrophage-lineage cells negatively regulate the hematopoietic stem cell pool in response to interferon gamma at steady state and during infection. Stem Cells 2015, 33:2294-2305.
40. Hynes R.O. Integrins: Bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
41. Schif-Zuck S., Gross N., Assi S., Rostoker R., Serhan C.N., Ariel A. Saturated-efferocytosis generates pro-resolving CD11b low macrophages: Modulation by resolvins and glucocorticoids. Eur J Immunol 2011, 41:366-379.
42. Cline M.J., Moore M.A. Embryonic origin of the mouse macrophage. Blood 1972, 39:842-849.
43. Palis J., Robertson S., Kennedy M., Wall C., Keller G. Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development 1999, 126:5073-5084.
44. Bertrand J.Y., Jalil A., Klaine M., Jung S., Cumano A., Godin I. Three pathways to mature macrophages in the early mouse yolk sac. Blood 2005, 106:3004-3011.
45. Davis J.M., Clay H., Lewis J.L., Ghori N., Herbomel P., Ramakrishnan L. Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 2002, 17:693-702.
46. Herbomel P., Thisse B., Thisse C. Ontogeny and behaviour of early macrophages in the zebrafish embryo. Development 1999, 126:3735-3745.
47. Li Y., Esain V., Teng L., et al. Inflammatory signaling regulates embryonic hematopoietic stem and progenitor cell production. Genes Dev 2014, 28:2597-2612.
48. Travnickova J., Tran Chau V., Julien E., et al. Primitive macrophages control HSPC mobilization and definitive haematopoiesis. Nat Commun 2015, 6:6227.
49. Gattazzo F., Urciuolo A., Bonaldo P. Extracellular matrix: A dynamic microenvironment for stem cell niche. Biochim Biophys Acta 2014, 1840:2506-2519.
50. Wynn T.A., Barron L. Macrophages: Master regulators of inflammation and fibrosis. Semin Liver Dis 2010, 30:245-257.
51. Lo Celso C., Scadden D.T. The haematopoietic stem cell niche at a glance. J Cell Sci 2011, 124:3529-3535.
52. Morrison S.J., Scadden D.T. The bone marrow niche for haematopoietic stem cells. Nature 2014, 505:327-334.
53. Chang K.H., Sengupta A., Nayak R.C., et al. p62 is required for stem cell/progenitor retention through inhibition of IKK/NF-kappaB/Ccl4 signaling at the bone marrow macrophage-osteoblast niche. Cell Rep 2014, 9:2084-2097.
54. Aiuti A., Webb I.J., Bleul C., Springer T., Gutierrez-Ramos J.C. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997, 185:111-120.
55. Broxmeyer H.E., Orschell C.M., Clapp D.W., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005, 201:1307-1318.
56. Bensinger W., DiPersio J.F., McCarty J.M. Improving stem cell mobilization strategies: Future directions. Bone Marrow Transplant 2009, 43:181-195.
57. To L.B., Levesque J.P., Herbert K.E. How I treat patients who mobilize hematopoietic stem cells poorly. Blood 2011, 118:4530-4540.
58. Arai F., Suda T. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann N Y Acad Sci 2007, 1106:41-53.
59. Nie Y., Han Y.C., Zou Y.R. CXCR4 is required for the quiescence of primitive hematopoietic cells. J Exp Med 2008, 205:777-783.
60. Ludin A., Itkin T., Gur-Cohen S., et al. Monocytes-macrophages that express alpha-smooth muscle actin preserve primitive hematopoietic cells in the bone marrow. Nat Immunol 2012, 13:1072-1082.
61. Massberg S., Schaerli P., Knezevic-Maramica I., et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 2007, 131:994-1008.
62. Dutta P., Hoyer F.F., Grigoryeva L.S., et al. Macrophages retain hematopoietic stem cells in the spleen via VCAM-1. J Exp Med 2015, 212:497-512.
63. Ramirez P., Rettig M.P., Uy G.L., et al. BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells. Blood 2009, 114:1340-1343.
64. Lieschke G.J., Grail D., Hodgson G., et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 1994, 84:1737-1746.
65. Schuettpelz L.G., Borgerding J.N., Christopher M.J., et al. G-CSF regulates hematopoietic stem cell activity, in part, through activation of Toll-like receptor signaling. Leukemia 2014, 28:1851-1860.
66. Levesque J.P., Hendy J., Takamatsu Y., Simmons P.J., Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003, 111:187-196.
67. Levesque J.P., Takamatsu Y., Nilsson S.K., Haylock D.N., Simmons P.J. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 2001, 98:1289-1297.
68. Semerad C.L., Christopher M.J., Liu F., et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 2005, 106:3020-3027.
69. Christopher M.J., Rao M., Liu F., Woloszynek J.R., Link D.C. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J Exp Med 2011, 208:251-260.
70. Strobl H., Scheinecker C., Csmarits B., Majdic O., Knapp W. Flow cytometric analysis of intracellular CD68 molecule expression in normal and malignant haemopoiesis. Br J Haematol 1995, 90:774-782.
71. Westerterp M., Gourion-Arsiquaud S., Murphy A.J., et al. Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. Cell Stem Cell 2012, 11:195-206.
72. Molineux G., Pojda Z., Dexter T.M. A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. Blood 1990, 75:563-569.
73. Takizawa H., Boettcher S., Manz M.G. Demand-adapted regulation of early hematopoiesis in infection and inflammation. Blood 2012, 119:2991-3002.
74. de Bruin A.M., Demirel O., Hooibrink B., Brandts C.H., Nolte M.A. Interferon-gamma impairs proliferation of hematopoietic stem cells in mice. Blood 2013, 121:3578-3585.
75. Nagai Y., Garrett K.P., Ohta S., et al. Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 2006, 24:801-812.
76. Schmid M.A., Takizawa H., Baumjohann D.R., Saito Y., Manz M.G. Bone marrow dendritic cell progenitors sense pathogens via Toll-like receptors and subsequently migrate to inflamed lymph nodes. Blood 2011, 118:4829-4840.
77. Boettcher S., Ziegler P., Schmid M.A., et al. Cutting edge: LPS-induced emergency myelopoiesis depends on TLR4-expressing nonhematopoietic cells. J Immunol 2012, 188:5824-5828.
78. Shi C., Jia T., Mendez-Ferrer S., et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating Toll-like receptor ligands. Immunity 2011, 34:590-601.
79. Basu S., Hodgson G., Katz M., Dunn A.R. Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation. Blood 2002, 100:854-861.
80. Bugl S., Wirths S., Radsak M.P., et al. Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling. Blood 2013, 121:723-733.
81. Cain D.W., Snowden P.B., Sempowski G.D., Kelsoe G. Inflammation triggers emergency granulopoiesis through a density-dependent feedback mechanism. PLoS One 2011, 6:e19957.
82. Bucher K., Schmitt F., Autenrieth S.E., et al. Fluorescent Ly6G antibodies determine macrophage phagocytosis of neutrophils and alter the retrieval of neutrophils in mice. J Leukoc Biol 2015, 98:365-372.
83. Hong C., Kidani Y., A-Gonzalez N., et al. Coordinate regulation of neutrophil homeostasis by liver X receptors in mice. J Clin Invest 2012, 122:337-347.
84. Xiang M., Yuan Y., Fan L., et al. Role of macrophages in mobilization of hematopoietic progenitor cells from bone marrow after hemorrhagic shock. Shock 2012, 37:518-523.
85. Boettcher S., Gerosa R.C., Radpour R., et al. Endothelial cells translate pathogen signals into G-CSF-driven emergency granulopoiesis. Blood 2014, 124:1393-1403.
86. Nathan C. Mechanisms and modulation of macrophage activation. Behring Inst Mitt 1991, 200-207.
87. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: An overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75:163-189.
88. Baldridge M.T., King K.Y., Boles N.C., Weksberg D.C., Goodell M.A. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 2010, 465:793-797.
89. MacNamara K.C., Oduro K., Martin O., et al. Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-gamma signaling. J Immunol 2011, 186:1032-1043.
90. De Bruin A.M., Libregts S.F., Valkhof M., Boon L., Touw I.P., Nolte M.A. IFNgamma induces monopoiesis and inhibits neutrophil development during inflammation. Blood 2012, 119:1543-1554.
91. Zhang Y., Jones M., McCabe A., Winslow G.M., Avram D., MacNamara K.C. MyD88 signaling in CD4 T cells promotes IFN-gamma production and hematopoietic progenitor cell expansion in response to intracellular bacterial infection. J Immunol 2013, 190:4725-4735.
92. Dufour C., Corcione A., Svahn J., et al. TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro. Blood 2003, 102:2053-2059.
93. Yang L., Dybedal I., Bryder D., et al. IFN-gamma negatively modulates self-renewal of repopulating human hemopoietic stem cells. J Immunol 2005, 174:752-757.
94. Zoumbos N.C., Gascon P., Djeu J.Y., Young N.S. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sci U S A 1985, 82:188-192.
95. Schurch C.M., Riether C., Ochsenbein A.F. Cytotoxic CD8(+) T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells. Cell Stem Cell 2014, 14:460-472.
96. Zoller E.E., Lykens J.E., Terrell C.E., et al. Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med 2011, 208:1203-1214.
97. Murray P.J., Young R.A., Daley G.Q. Hematopoietic remodeling in interferon-gamma-deficient mice infected with mycobacteria. Blood 1998, 91:2914-2924.
98. MacNamara K.C., Racine R., Chatterjee M., Borjesson D., Winslow G.M. Diminished hematopoietic activity associated with alterations in innate and adaptive immunity in a mouse model of human monocytic ehrlichiosis. Infect Immun 2009, 77:4061-4069.
99. Jordan S., Ruzsics Z., Mitrovic M., et al. Natural killer cells are required for extramedullary hematopoiesis following murine cytomegalovirus infection. Cell Host Microbe 2013, 13:535-545.
100. Jordan M.B., van Rooijen N., Izui S., Kappler J., Marrack P. Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model. Blood 2003, 101:594-601.
101. Bronte V., Pittet M.J. The spleen in local and systemic regulation of immunity. Immunity 2013, 39:806-818.
102. Griseri T., McKenzie B.S., Schiering C., Powrie F. Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity 2012, 37:1116-1129.
103. Siracusa M.C., Saenz S.A., Wojno E.D., et al. Thymic stromal lymphopoietin-mediated extramedullary hematopoiesis promotes allergic inflammation. Immunity 2013, 39:1158-1170.
104. Belyaev N.N., Biro J., Langhorne J., Potocnik A.J. Extramedullary myelopoiesis in malaria depends on mobilization of myeloid-restricted progenitors by IFN-gamma induced chemokines. PLoS Pathog 2013, 9:e1003406.
105. Hoeksema M.A., Scicluna B.P., Boshuizen M.C., et al. IFN-gamma priming of macrophages represses a part of the inflammatory program and attenuates neutrophil recruitment. J Immunol 2015, 194:3909-3916.
106. Bleriot C., Dupuis T., Jouvion G., Eberl G., Disson O., Lecuit M. Liver-resident macrophage necroptosis orchestrates type 1 microbicidal inflammation and type-2-mediated tissue repair during bacterial infection. Immunity 2015, 42:145-158.